Clinical trial
Efficacy Study on Early Versus Late Abciximab Administration During Primary…
NCT00354406 · University of Pisa, Other · Completed
Key facts
| NCT number | NCT00354406 |
|---|---|
| Title | Efficacy Study on Early Versus Late Abciximab Administration During Primary Coronary Angioplasty |
| Official title | A Randomized Trial Comparing the Efficacy on Myocardial Infarct Size Reduction of Early vs. Late Abciximab Administration During Primary Percutaneous Coronary Angioplasty |
| Lead sponsor | University of Pisa, Other |
| Collaborators | Eli Lilly and Company Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Myocardial Infarction |
| Intervention type | Drug |
| Interventions | abciximab |
| Enrollment | 110 |
| Start date | Apr 1, 2006 |
| Primary completion | Nov 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Jul 20, 2006 |
| Last update posted | Nov 16, 2011 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: